Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial - Galsky, M D; Arija, JÁA; Bamias, A; IMvigor130 Study Group (Lancet, 2020)
(10236):